COVID-19 y dolorqué conocemos hasta ahora

  1. María Teresa Fernández Martín 1
  2. Esperanza Ortigosa Solórzano 2
  1. 1 Hospital Universitario Río Hortega, Valladolid
  2. 2 Hospital Universitario de Getafe, Madrid
Revista:
MPJ Multidisciplinary Pain Journal

ISSN: 2697-2263

Año de publicación: 2021

Número: 1

Tipo: Artículo

Otras publicaciones en: MPJ Multidisciplinary Pain Journal

Resumen

El SARS-CoV-2 es un nuevo coronavirus extendido por todo el mundo que ha obligado a la declaración de pandemia por la Organización Mundial de la Salud. Su sintomatología, que varía desde síntomas gripales hasta la muerte, ha supuesto una fractura en la vida de la población, afectando también a la atención sanitaria. Hemos realizado una búsqueda bibliográfica sistemática en las principales bases de datos online (PubMed, Medline, UpToDate, Embase, Scopus y Cochrane Library) con las siguientes palabras clave: “COVID-19”, “coronavirus and SARS-CoV-2”, “pain”, “chronic pain”. Se han incluido publicaciones desde la descripción de la enfermedad hasta diciembre de 2020, acerca de la repercusión que ha tenido sobre el dolor en sus diferentes ámbitos, las características clínicas y su manejo.

Referencias bibliográficas

  • Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. 2019. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
  • Declaración Universal de los Derechos Humanos. Disponible en: http://www.un.org/es/documents/udhr [último acceso 18 febrero de 2021].
  • Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. DOI: 10.1111/joim.13091.
  • Song XJ, Xiong DL, Wang ZY. Pain management during the COVID-19 pandemic in China: lessons learned. Pain Med. 2020;21(7):1319-23. DOI: 10.1093/pm/pnaa143.
  • Young BE, Ong SWX, Kalimuddin S. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323:1488-94. DOI: 10.1001/jama.2020.3204.
  • Loeser JD, Treede RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain. 2008;137:473-7. DOI: 10.1016/j.pain.2008.04.025.
  • Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ. 2010;182:349-55. DOI: 10.1503/cmaj.091823.
  • Hui DS, Chan MC, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J. 2004;80:373-81. DOI: 10.1136/pgmj.2004.020263.
  • Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. DOI: 10.1186/1471-2377-11-37.
  • Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575. DOI: 10.1136/bmj.38933.585764.AE.
  • Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9:e59177. DOI: 10.7554/eLife.59177.
  • Clauw DJ, Häuser W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161:1694-7. DOI: 10.1097/j.pain.0000000000001950.
  • Beggs S, Liu XJ, Kwan C, Salter MW. Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol Pain. 2010;6:74. DOI: 10.1186/1744-8069-6-74.
  • Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995-8. DOI: 10.1021/acschemneuro.0c00122.
  • Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, et al. Emerging neurological and psychobiological aspects of COVID-19 infection. Brain Sci. 2020;10(11):852. DOI: 10.3390/brainsci10110852.
  • Gandhi S, Srivastava AK, Ray U, Tripathi PP. Is the collapse of the respiratory center in the brain responsible for respiratory breakdown in COVID-19 patients? ACS Chem Neurosci. 2020;11:1379-81.
  • Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2020;30:1-3.
  • Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6:521-32. DOI: 10.1038/nrn1700.
  • Liu MM, Reidy AB, Saatee S. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017;127:166-72. DOI: 10.1097/ALN.0000000000001659.
  • Kosciuczuk U, Knapp P, Lotowska-Cwiklewska AM. Opioid-induced immunosuppression and carcinogenesis promotion theories create the newest trend in acute and chronic pain pharmacotherapy. Clinics (Sao Paulo, Brazil). 2020;75:1554. DOI: 10.6061/clinics/2020/e1554.
  • Franchi S, Moschetti G, Amodeo G. Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies. Front Immunol. 2019;10:2914. DOI: 10.3389/fimmu.2019.02914.
  • Saurer TB, Carrigan KA, Ijames SG. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol. 2006;173:3-11. DOI: 10.1016/j.jneuroim.2005.11.009.
  • McLean SA, Clauw DJ. Predicting chronic symptoms after an acute “stressor”-lessons learned from 3 medical conditions. Med Hypotheses. 2004;63:653-8. DOI: 10.1016/j.mehy.2004.03.022.
  • Bendau A, Petzold MB, Pyrkosch L, Mascarell Maricic L, Betzler F, Rogoll J, et al. Associations between COVID-19 related media consumption and symptoms of anxiety, depression and COVID-19 related fear in the general population in Germany. Eur Arch Psychiatry Clin Neurosci. 2020 Jul 20;1-9. DOI: 10.1007/s00406-020-01171-6.
  • Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and Positivity: Mediating role of intolerance of uncertainty, depression, anxiety, and stress. Int J Ment Health Addict. 2020 May 28;1-14. DOI: 10.1007/s11469-020-00331-y.
  • Chan D, Xu Feng Lin, Jane MG, Liu CW. Clinical challenges and considerations in management of chronic paipatients during a COVID-19 pandemic. Ann Acad Med Singap. 2020;49:669-73. DOI: 10.47102/annals-acadmedsg.2020130.
  • Malhotra N, Joshi M, Datta R, Bajwa SJ, Mehdiratta L. Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement regarding COVID19. Indian J Anaesth. 2020;64:25963. DOI: 10.4103/ija.IJA_288_20.
  • Sarzi-Puttini P, Vellucci R, Zuccaro SM. The appropriate treatment of chronic pain. Clin Drug Investig. 2012;32:21-33. DOI: 10.2165/11630050-000000000-00000.
  • Ghai B, Malhotra N,Jit S S. Telemedicine for chronic pain management during COVID-19 pandemic. Indian J Anaesth. 2020; 64:456-46. DOI: 10.4103/ija.IJA_652_20.
  • Shanthanna H, Strand NH, Provenzano DA, Lobo CA, Eldabe S, Bhatia A, et al. Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel. Anaesthesia. 2020;75:935-44. DOI: 10.1111/anae.15076.
  • Cohen SP, Baber ZB, Buvanendran A, McLean LTCBC, Chen Y, Hooten WM, et al. Pain management best practices from multispecialty organizations during the COVID-19 pandemic and public health crises. Pain Med. 2020;21:1331-46. DOI: 10.1093/pm/pnaa127.
  • Chauhan V, Galwankar S, Arquilla B, Garg M, Somma SD, El-Menyar A, et al. Novel coronavirus (COVID-19): Leveraging telemedicine to optimize care while minimizing exposures and viral transmission. J Emerg Trauma Shock. 2020;13:20-4.
  • Ayyagari A, Bhargava A, Agarwal R, Mishra SK, Mishra AK, Das SR, et al. Use of telemedicine in evading cholera outbreak in MahakumbhMela, Prayag, UP, India: An encouraging experience. Telemed J E Health. 2003;9:89-94. DOI: 10.1089/153056203763317693.
  • Slattery BW, Haugh S, O’Connor L, Francis K, Dwyer CP, O’Higgins S, et al. An evaluation of the effectiveness of the modalities used to deliver electronic health interventions for chronic pain: Systematic review with network meta-analysis. J Med Internet Res. 2019;17:e1108. DOI: 10.2196/11086.
  • Sundararaman LV, Edwards RR, Ross EL, Jamison RN. Integration of mobile health technology in the treatment of chronic pain: A critical review. RegAnesth Pain Med. 2017;42:488-98. DOI: 10.1097/AAP.0000000000000621.
  • Fisher E, Law E, Dudeney J, Eccleston C, Palermo TM. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2019;4:CD011118. DOI: 10.1002/14651858.CD011118.pub3.
  • Cook AJ, Roberts DA, Henderson MD, Van Winkle LC, Chastain DC, Hamill-Ruth RJ. Electronic pain questionnaires: A randomized, crossover comparison with paper questionnaires for chronic pain assessment. Pain. 2004;110:310-7. DOI: 10.1016/j.pain.2004.04.012.
  • Azevedo BR, Oliveira CB, Araujo GMD, Silva FG, Damato TM, Pinto RZ, et al. Is there equivalence between the electronic and paper version of the questionnaires for assessment of patients with chronic low back pain? Spine. 2020;45:E329-35. DOI: 10.1097/BRS.0000000000003281.
  • Chhabra HS, Sharma S, Verma S. Smartphone app in self-management of chronic low back pain: A randomized controlled trial. Eur Spine J. 2018;27:2862-74. DOI: 10.1007/s00586-018-5788-5.
  • Flodgren G, Rachas A, Farmer AJ, Inzitari M, Shepperd S. Interactive telemedicine: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015;2015:CD002098. DOI: 10.1002/14651858.CD002098.pub2.
  • Baker J, Stanley A. Telemedicine technology: A review of services, equipment, and other aspects. Curr Allergy Asthma Rep. 2018;18:60. DOI: 10.1007/s11882-018-0814-6.
  • Boodley CA. Primary care telehealth practice. J Am Acad Nurse Pract. 2006;18:343-5. DOI: 10.1111/j.1745-7599.2006.00146.x.
  • Aguarwal N, Jain P, Pathak R, Gupta R. Telemedicine in India: A tool for transforming health care in the era of COVID-19 pandemic.J Educ Health Promot. 2020;9:190. DOI: 10.4103/jehp.jehp_472_20.
  • Lovell N, Maddocks M, Etkind SN, Taylor K, Carey I, Vora V, et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. J Pain Symptom Manage. 2020;60:77-81. DOI: 10.1016/j.jpainsymman.2020.04.015.
  • Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125:436-40. DOI: 10.1016/j.bja.2020.05.021.
  • Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020;41:1667-71. DOI: 10.1007/s10072-020-04486-3.
  • Nieto R, Pardo R, Sora B, Feliu-Soler A, Luciano JV. Impact of COVID-19 lockdown measures on spanish people with chronic pain: an online study survey. J Clin Med. 2020;9:3558. DOI: 10.3390/jcm9113558.
  • Uygun Ö, Ertaş M, Ekizoğlu E, Bolay H, Özge A, Orhan EK, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain. 2020;21:121. DOI: 10.1186/s10194-020-01188-1.
  • Sampaio Rocha-Filho PA, Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. 2020;60:1797-9. DOI: 10.1111/head.13941.
  • Yamani N, Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. J Headache Pain. 2019;20:80. DOI: 10.1186/s10194-019-1022-z.
  • Salaffi F, Giorgi V, Sirotti S, Bongiovanni S, Farah S, Bazzichi L, et al. The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clin Exp Rheumatol. 2020;16.
  • Consonni M, Telesca A, Grazzi L, Cazzato D, Lauria G. Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine Neurol Sci. 2021;42(2):389-97.
  • Serrano-Ibáñez ER, Esteve R, Ramírez-Maestre C, Ruiz-Párraga GT, López-Martínez AE. Chronic pain in the time of COVID-19: Stress aftermath and central sensitization. Br J Health Psychol. 2020. DOI: 10.1111/bjhp.12483. Online ahead of print.